Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Biochemical and Biophysical Research Communications|October 11, 2003
[LysB3, GluB29] insulin: a novel insulin analog with enhanced beta-cell protective actionIrini Rakatzi, Gerhard Seipke, Jürgen EckelInternational Journal of Toxicology|March 3, 2006
Insulin glulisine--a comprehensive preclinical evaluationIngo Stammberger, Gerhard Seipke, Thomas BartelsEuropean Endocrinology|April 11, 2018
Equivalent Recombinant Human Insulin Preparations and their Place in TherapyJuergen Sandow, Wolfgang Landgraf, Reinhard Becker, et al.Drugs|May 29, 2014
The evolution of insulin glargine and its continuing contribution to diabetes careRolf Hilgenfeld, Gerhard Seipke, Harald Berchtold, et al.Diabetes|August 28, 2003
A novel insulin analog with unique properties: LysB3,GluB29 insulin induces prominent activation of insulin receptor substrate 2, but marginal phosphorylation of insulin receptor substrate 1Irini Rakatzi, Stefanie Ramrath, Daniela Ledwig, et al.Plos One|March 9, 2010
In vitro metabolic and mitogenic signaling of insulin glargine and its metabolitesMark R Sommerfeld, Günter Müller, Georg Tschank, et al.Pageof 1